Artelo Biosciences, Inc. (ARTL) vs Bone Biologics Corporation (BBLG)

A side-by-side comparison of Artelo Biosciences, Inc. and Bone Biologics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artelo Biosciences, Inc. logo
ARTL
Artelo Biosciences, Inc.
$1M
$3.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Bone Biologics Corporation logo
BBLG
Bone Biologics Corporation
$878396
$0.49HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ARTL vs BBLG

growth of $100 · dividends reinvested · last 5y
ARTL -99.4% (-64.6%/yr)BBLG -100.0% (-82.9%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020222023202420252026$1$0
ARTL BBLG

ARTL vs BBLG: by the numbers

  • •ARTL is the larger company ($1M vs $878396 market cap).

Metrics side by side

Valuation

MetricARTLBBLG
P/B ratio0.270.22

Profitability

MetricARTLBBLG
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-253.57%-73.66%
ROIC-219.36%-78.01%

Growth (annualized)

MetricARTLBBLG
Total return CAGR (5Y)-64.27%N/A

Go deeper

Full ARTL analysisFull BBLG analysisInteractive comparison tool

Dig into the metrics

Artelo Biosciences ROEBone Biologics ROEArtelo Biosciences operating marginBone Biologics operating marginArtelo Biosciences revenue growthBone Biologics revenue growthArtelo Biosciences free cash flowBone Biologics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.